@article {Douglas5, author = {J. F. Douglas and B. J. Ludwig and T. Ginsberg and F. M. Berger}, title = {THE METABOLIC FATE OF MEBUTAMATE (CAPLA)}, volume = {136}, number = {1}, pages = {5--9}, year = {1962}, publisher = {American Society for Pharmacology and Experimental Therapeutics}, abstract = {Mebutamate is absorbed rapidly into the bloodstream of man, reaching a peak concentration between the first and second hours after oral administration. The metabolism of mebutamate leads to at least three urinary end-products: unchanged drug present in small quantities, a hydroxylated derivative, 2-methyl-2-(β-hydroxyl-α-methylpropyl)-1,3-propanediol dicarbamate, which is the primary metabolite and a glucuronide conjugate.}, issn = {0022-3565}, URL = {https://jpet.aspetjournals.org/content/136/1/5}, eprint = {https://jpet.aspetjournals.org/content/136/1/5.full.pdf}, journal = {Journal of Pharmacology and Experimental Therapeutics} }